Tetra Discovery Partners

Tetra Discovery Partners is a biotechnology company focused on clinical-stage drug development. The company has developed a series of pharmaceutical products aimed at helping patients with Alzheimer's disease and other brain disorders achieve clearer thinking. Among these, the compound BPN14770 is a negative allosteric modulator of the phosphodiesterase 4D (PDE4D) gene, playing a crucial role in forming brain cell connections, enhancing learning, and memory formation.